Le Lézard
Classified in: Health, Science and technology
Subject: Award

Omkar Marathe, MD, of The Oncology Institute of Hope and Innovation Selected for 40 Under 40 in Cancer Award


The Oncology Institute of Hope and Innovation (TOI) is proud to announce that Omkar Marathe, MD, a TOI physician, has received the "40 Under 40 in Cancer" award.

The 40 Under 40 in Cancer award celebrates the contributions of emerging leaders in cancer care under the age of 40. The award's sponsors include the Association for Value-Based Cancer Care.

Dr. Marathe treats patients with cancer and blood disorders in the greater Long Beach Area and has received a teaching award for his work with the St. Mary's Internal Medicine residency program. He has conducted research and published papers in various disciplines of oncology including ocular melanoma and HER2+ breast cancer and was recently named Director for TOI's highly esteemed clinical trials program. Dr. Marathe is fluent in English, Spanish, Marathi, and conversational Hindi.

Brad Hively, TOI's CEO, commented: "All of us at The Oncology Institute are incredibly proud of our colleague Dr. Marathe for being selected for this award. He represents what's best about our company: a dedicated and talented clinician providing innovative and compassionate cancer care to our patients."

About The Oncology Institute of Hope and Innovation

Founded in 2007, The Oncology Institute of Hope and Innovation (TOI) is one of the largest community oncology practices in the US as well as our nation's leading value-based oncology services platform. TOI employs 75 physicians and mid-level practitioners in 42 clinic locations, with more than 500 total employees helping to offer leading-edge, evidence-based cancer care to a population of more than 1.5 million patients. TOI brings comprehensive, integrated cancer care into community settings, including clinical trials, palliative care programs, stem cell transplants, transfusions, and other care delivery models traditionally associated with the most advanced tertiary care settings. For more information visit www.theoncologyinstitute.com.


These press releases may also interest you

at 17:00
SpryPoint Unveils Embedded Payment Solution for SpryCIS and SpryEngage Platforms
SpryPoint, the leading enterprise software-as-a-service (SaaS) provider to Utilities across North America, is proud to announce the upcoming release of SpryWallet, an embedded payment solution designed specifically for the SpryCIS and SpryEngage...

at 16:55
Veterinary Management Groups (VMG) Launches Innovative Veterinary Economic Dashboard
Veterinary Management Groups (VMG) is proud to...

at 16:53
Celebrating Connectivity: telMAX brings Canada's Fastest Internet to The City of Richmond Hill.
telMAX broke ground today in Richmond Hill with the commencement of a state-of-the-art fibre Internet infrastructure project that will deliver all-fibre Internet connectivity to residents and businesses throughout the community....

at 16:35
Bragg Announces US$7 Million Secured Note Financing
Bragg Gaming Group Inc. ("Bragg" or the "Company"), a global B2B gaming technology and content provider, today announced the issuance of a secured promissory note in the principal amount of US$7 million (the "Note") to certain entities controlled by...

at 16:30
Scienjoy Holding Corporation Reports Fiscal Year 2023 Financial Results
Scienjoy Holding Corporation ("Scienjoy", the "Company", or "we") , an interactive entertainment leader in the Chinese market, today announced its financial results for the year ended December 31, 2023. Fiscal Year 2023 Operating and Financial...

at 16:30
Farmmi Receives NASDAQ Notification Regarding Minimum Bid Requirements
Farmmi, Inc. ("Farmmi" or the "Company") , an agriculture products supplier in China, today announced that on April 22, 2024, it received a letter from The Nasdaq Stock Market LLC ("Nasdaq"), notifying the Company that it is currently not in...

More news about Science and technology...


News published on and distributed by: